What is Opus Genetics's interest expense, nonoperating?

Opus Genetics (IRD) reported interest expense, nonoperating of $69K in Q1 2026.

What does interest expense, nonoperating mean?

Reflects the interest costs incurred on debt obligations that are not directly related to the primary operating activities of the business. For biopharmaceutical companies, this typically represents the cost of servicing debt used to fund clinical trials or general corporate operations. Monitoring this helps assess the company's leverage and the sustainability of its debt structure.

Opus Genetics IRD Interest Expense, Nonoperating

Interest Expense, Nonoperating at other companies

Cal-Maine FoodsCALM

$153K+11.5%

Dakota GoldDC

$34.37K—

Evommune EVMN

$25.8K-72.9%

Ondas, Inc. ONDS

$338K-91.3%

Quantum Computing Inc.QUBT

$171K+195%

Capricor TherapeuticsCAPR

$761.43K—

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's interest expense, nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's interest expense, nonoperating?: Opus Genetics (IRD) reported interest expense, nonoperating of $69K in Q1 2026.
What does interest expense, nonoperating mean?: Reflects the interest costs incurred on debt obligations that are not directly related to the primary operating activities of the business. For biopharmaceutical companies, this typically represents the cost of servicing debt used to fund clinical trials or general corporate operations. Monitoring this helps assess the company's leverage and the sustainability of its debt structure.